Holmes Biopharma, Inc. (LMB) Earnings
|
Expand Research on LMB
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +52.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -15.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | $1.22 | N/A | N/A | $215.37M | = | N/A | N/A | ||
| 8/4/26 |
Q226 | $0.64 | $0.94 | -$0.30 | $173.45M | $177.33M | = |  | | Details | |
| 5/5/26 | Q126 | $0.64 | $0.21 | +$0.43 | $138.9M | $134.14M | = | | | Details | |
| 3/2/26 | Q425 | $1.40 | $1.21 | +$0.19 | $186.9M | $198.45M | = | | | Details | |
| 11/4/25 |
Q325 | N/A | $1.17 | N/A | N/A | $184.48M | = | N/A | N/A | ||
| 8/5/25 | Q225 | $0.93 | $0.77 | +$0.16 | $142.2M | $145.68M | = | | | Details | |
| 5/5/25 | Q125 | $1.12 | $0.43 | +$0.69 | $133.1M | $120.48M | = | | | Details | |
| 3/10/25 | Q424 | $1.15 | $0.79 | +$0.36 | $143.65M | $149.37M | = | | | Details |
